Publications by authors named "Kiran Musunuru"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

744,068

Total Likes

45,803

Extended Reach

3,909,424

Social Features

281
P
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease.
Kiran Musunuru, Sarah A Grandinette, Xiao Wang, Taylor R Hudson, Kevin Briseno, Anne Marie Berry, Julia L Hacker, Alvin Hsu, Rachel A Silverstein, Logan T Hille

June 2025

Videos about Article: user user user 10

13 26 4 233 24 579

View All Article and Social Media Activity
G
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy.
Lisa N Kasiewicz, Souvik Biswas, Aaron Beach, Huilan Ren, Chaitali Dutta, Anne Marie Mazzola, Ellen Rohde, Alexandra Chadwick, Christopher Cheng, Sara P Garcia

Nat Commun· May 2023

Videos about Article: user

1 7 2 2

View All Article and Social Media Activity
H
How to create personalized gene editing platforms: Next steps toward interventional genetics.
Rebecca C Ahrens-Nicklas, Kiran Musunuru

Am J Hum Genet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-directed base editing of prevents ectopic calcification in a variant-humanized mouse model of pseudoxanthoma elasticum.
Lauren C Testa, Dora Obiri-Yeboah, Hooda Said, Ping Qu, Michael A Levine, Kiran Musunuru

Mol Ther Nucleic Acids· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Base editing strategies for correction of two highly recurrent phenylketonuria variants.
Aidan Quigley, Ishaan Jindal, Thomas Campion, Delaney Rutherford, Yongseok Han, Kiran Musunuru

Mol Ther Nucleic Acids· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthroughs in targeted in vivo gene editing: Overcoming barriers to effective delivery.
Paula Cannon, Kiran Musunuru

Mol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OxLDL-Targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque Development.
Robert D Schwab, David Degaramo, Seok Jae Hong, Xin Bi, Aisha Faruqi, Kiran Musunuru

Circulation· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement and clinical interpretation of CRISPR off-targets.
Ariella Angelini Stewart, Rebecca C Ahrens-Nicklas, Shengdar Q Tsai, Kiran Musunuru, Petros Giannikopoulos

Nat Genet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher.
Fyodor Urnov, Sadik Kassim, Kiran Musunuru, David Liu, Ann Lee

Cytotherapy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs.
Madelynn N Whittaker, Lauren C Testa, Aidan Quigley, Dominique L Brooks, Sarah A Grandinette, Kiran Musunuru

Nat Biomed Eng· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy and genome editing for lipoprotein disorders.
Chen Gurevitz, Archna Bajaj, Amit V Khera, Ron Do, Heribert Schunkert, Kiran Musunuru

Eur Heart J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving Therapeutic Genome Editing into Global Clinical Trials and Medicine.
Kiran Musunuru, Fyodor Urnov

CRISPR J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable.
Sadik H Kassim, Fyodor Urnov, Kiran Musunuru, Ann Lee, Luis Barrera

Nat Biotechnol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo.
Vladimir V Shuvaev, Ying K Tam, Benjamin W Lee, Jacob W Myerson, Alan Herbst, Kiran Musunuru

Proc Natl Acad Sci U S A· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building Better Medicine: Translational Justice and the Quest for Equity in US Healthcare.
Megan A Allyse, Preya Agam, Yvonne Bombard, Roel Feys, McKenna Horstmann, Kiran Musunuru

Am J Bioeth· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved specificity and efficiency of adenine base editing therapies with hybrid guide RNAs.
Madelynn N Whittaker, Lauren C Testa, Dominique L Brooks, Aidan Quigley, Hooda Said, Kiran Musunuru

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Milestone for Gene-Editing Therapies.
Kiran Musunuru

N Engl J Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grounded in Reality: Integrating Community Values and Priorities of End Users in Human Gene Editing.
Kirsten A Riggan, Roel Feys, Assata Kokayi, Karen M Meagher, Marsha Michie, Kiran Musunuru

Am J Bioeth· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Harding and Martinez.
Dominique L Brooks, Kiran Musunuru, Xiao Wang

HGG Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An epigenetic editor to silence genes.
Madelynn N Whittaker, Kiran Musunuru

Science· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource of Gene Expression Data From a Multiethnic Population Cohort of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Wenjian Lv, Apoorva Babu, Michael P Morley, Kiran Musunuru, Marie A Guerraty

Circ Genom Precis Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A base editing strategy using mRNA-LNPs for in vivo correction of the most frequent phenylketonuria variant.
Dominique L Brooks, Madelynn N Whittaker, Hooda Said, Garima Dwivedi, Ping Qu, Kiran Musunuru

HGG Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need.
Dominique L Brooks, Madelynn N Whittaker, Ping Qu, Kiran Musunuru, Rebecca C Ahrens-Nicklas

Am J Hum Genet· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes.
Madelynn N Whittaker, Lauren C Testa, Aidan Quigley, Ishaan Jindal, Saúl V Cortez-Alvarado, Kiran Musunuru

Arterioscler Thromb Vasc Biol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Playing the genetic lottery: an interview with Kiran Musunuru.
Kiran Musunuru

Dis Model Mech· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A common coding variant in BAG3 protects from heart failure.
Xiao Wang, Kiran Musunuru

Nat Cardiovasc Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis